|
As President of Manhattan Research, Mark Bard is responsible for the overall strategic guidance of the company including the design of consumer and physician marketing data sets, writing healthcare industry reports, and consulting with Manhattan Research clients regarding the optimization of their marketing investments.Prior to founding Manhattan Research, Mr. Bard was the Group Director of the Health Practice at Cyber Dialogue, a marketing services firm based in New York. Prior to that, he was a strategy consultant in New York focused on the pharmaceutical and biotechnology sectors. His professional experience also includes time with the managed care and business development division of Glaxo SmithKline, a leading global pharmaceutical company.Mr. Bard is a nationally recognized health industry expert on topics including online health, information technology trends, pharmaceutical marketing, and disease management. He is also the author of numerous articles and book chapters covering topics such as health administration, health software, and the Internet’s impact on health. He is regularly quoted in leading publications and media outlets such as Pharmaceutical Executive, Wall Street Journal, Washington Post, USA Today, ABC News, NY Times, Health IT, Computerworld, Science, Next Generation Pharmaceuticals and Boston Globe.Mr. Bard received an M.B.A. from Kenan-Flagler Business School at the University of North Carolina at Chapel Hill, an M.H.A. from the School of Public Health at UNC-Chapel Hill, and a B.S. in health administration from James Madison University. | 